INTERNATIONAL PATENT: EPIGENIC THERAPEUTICS,INC., 益杰立科（上海）生物科技有限公司 FILES APPLICATION FOR "ENGINEERED GENE TRANSCRIPTION REPRESSIONAL TOOL TARGETING INHIBIN SUBUNIT ΒE (INHBE) AND USE THEREOF"

GENEVA, Dec. 29 -- EPIGENIC THERAPEUTICS , INC. (Floor 5 & 6, Unit 1, Building 4, No. 160, Basheng Road, China (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 200131), 益杰立科（上海）生物科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区巴圣路160号4号楼一单元5层&6层) filed a patent application (PCT/CN2025/102298) for "ENGINEERED GENE TRANSCRIPTION REPRESSIONAL TOOL TARGETING INHIBIN SUBUNIT BetaE (INHBE) AND USE THEREOF" on Jun 20, 2...